Overview

The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis

Status:
Completed
Trial end date:
2019-02-28
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the mechanisms underlying the effect of incretin therapy on lipoprotein metabolism in subjects with type 2 diabetes and to study the effect of liraglutide on hepatic de novo lipogenesis.
Phase:
Phase 4
Details
Lead Sponsor:
Helsinki University Central Hospital
Collaborator:
Göteborg University
Treatments:
Liraglutide